These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34559109)

  • 1. Neuromyelitis optica spectrum disorder with active replication of hepatitis B virus and seropositive anti-aquaporin-4 antibody: A case report.
    Lei J; Wang H
    Medicine (Baltimore); 2021 Sep; 100(38):e27207. PubMed ID: 34559109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of patients with neuromyelitis optica spectrum disorder (NMOSD) combined with chronic hepatitis B (CHB) infection and seropositive for anti-aquaporin-4 antibody.
    Liu J; Xu L; Chen ZL; Li M; Yi H; Peng FH
    Bosn J Basic Med Sci; 2018 Feb; 18(1):35-42. PubMed ID: 29144890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review.
    Tao S; Zhang Y; Ye H; Guo D
    Mult Scler Relat Disord; 2019 Oct; 35():185-192. PubMed ID: 31398657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
    Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: Identification of Hepatitis B Virus in the cerebrospinal fluid of neuromyelitis optica spectrum disorders and successful treatment with ofatumumab and inebilizumab.
    Cai L; Liu X; Zhou H; Li J; Zhou D; Hong Z
    Front Immunol; 2024; 15():1351782. PubMed ID: 38426084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intractable nausea and vomiting as an uncommon presentation in an anti-aquaporin 4-positive patient.
    Wang L; Su HJ; Qi JL; E RF; Zhao K
    J Int Med Res; 2018 Aug; 46(8):3411-3416. PubMed ID: 29806512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent optic neuritis in a patient with Sjogren syndrome and neuromyelitis optica spectrum disorder: A case report.
    Zheng W; Liu X; Hou X; Zhu Y; Zhang T; Liao L
    Medicine (Baltimore); 2020 Nov; 99(45):e23029. PubMed ID: 33157952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCB1 gene polymorphisms impact the effect of high-dose intravenous methylprednisolone therapy on optic neuritis associated with AQP4-IgG-positive neuromyelitis optica spectrum disorder.
    Dai Y; Ni S; Wu F; Guo S; Zhao X; Wang J
    J Clin Pharm Ther; 2022 Sep; 47(9):1379-1387. PubMed ID: 35488449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing intravenous methylprednisolone pulse therapy in Chinese patients with isolated optic neuritis associated with AQP4 antibody-seropositive neuromyelitis optica.
    Guo S; Jiang H; Jiang L; Peng J; Liu H; Wang J; Wei W
    Sci Rep; 2021 Nov; 11(1):22229. PubMed ID: 34782653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder.
    Yaguchi H; Sakushima K; Takahashi I; Nishimura H; Yashima-Yamada M; Nakamura M; Tsuzaka K; Maruo Y; Takahashi T; Yabe I; Sasaki H
    Intern Med; 2013; 52(9):969-72. PubMed ID: 23648715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review.
    Anamnart C; Tisavipat N; Owattanapanich W; Apiwattanakul M; Savangned P; Prayoonwiwat N; Siritho S; Rattanathamsakul N; Jitprapaikulsan J
    Mult Scler Relat Disord; 2022 Feb; 58():103414. PubMed ID: 35216789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden onset of sleep due to hypothalamic lesions in neuromyelitis optica spectrum disorder positive for anti-aquaporin-4 antibody.
    Okuma H; Matsumura K; Hatanaka Y; Saito F; Sonoo M
    Mult Scler; 2014 Sep; 20(10):1407-8. PubMed ID: 25160125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level.
    Nishimura H; Enokida H; Sakamoto T; Takahashi T; Hayami H; Nakagawa M
    J Artif Organs; 2018 Sep; 21(3):378-382. PubMed ID: 29675599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
    Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D
    J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: A multicenter cohort study.
    Kessler RA; Mealy MA; Jimenez-Arango JA; Quan C; Paul F; López R; Hopkins S; Levy M
    Mult Scler Relat Disord; 2017 Oct; 17():198-201. PubMed ID: 29055457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic amyotrophic lateral sclerosis with seropositive neuromyelitis optica spectrum disorder: A case report.
    Kim JY; Oh HJ; Kim Y; Seok JM
    Medicine (Baltimore); 2021 Apr; 100(16):e25580. PubMed ID: 33879715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromyelitis optica spectrum disorders in South of Tunisia: A rare entity with low seroprevalence of anti-aquaporin 4 autoantibodies.
    Mejdoub S; Feki S; Dammak M; Farhat N; Hdiji O; Boukthir S; Hachicha H; Mhiri C; Masmoudi H
    Rev Neurol (Paris); 2020 May; 176(4):261-267. PubMed ID: 31668529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromyelitis Optica Spectrum Disorders.
    Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
    Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low T3 syndrome in neuromyelitis optica spectrum disorder: Associations with disease activity and disability.
    Cho EB; Min JH; Cho HJ; Seok JM; Lee HL; Shin HY; Lee KH; Kim BJ
    J Neurol Sci; 2016 Nov; 370():214-218. PubMed ID: 27772762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.